Health Organizations' (WHO; Geneva, Switzerland) definition of blindness, it is estimated that number of people with visual impairment (presenting vision) is 285 million (65% of whom are aged over 50 years). Of these, 246 million have low vision (63% over 50) and 39 million are estimated to be blind (82% over 50). Infectious conditions such as trachoma and corneal ulcer are common in the developing world, whereas non-infectious and infectious entities like corneal dystrophies, pseudophakic bullous keratopathy and herpetic eye disease are more common causes of corneal blindness in developed countries. [2] [3] [4] [5] [6] Many corneal diseases are treatable by transplantation using donated corneal tissue by penetrating keratoplasty, lamellar keratoplasty, or endothelial keratoplasty. However, success is limited in conditions that involve corneal nerve damage, such as trauma or infection (bacteria, fungal or viral); or pathologies that chronically disrupt the ocular surface mucosa (ocular cicatricial pemphigoid and Stevens-Johnson's syndrome) or disrupt tear production (Sjögren syndrome) or injuries (severe chemical and thermal burns) that destroy the limbal stem cell niches (limbal stem cell deficiency [LSCD] ). Allotransplantation has a poor prognosis also in eyes with corneal dystrophy if there has been a previously rejected graft. Furthermore, the infrastructure necessary for a corneal transplant service is not available in many parts of the world, even in some developed countries, 8 because of limitations in the facilities for storage and distribution of corneal tissue or insurgical training and availability of surgeons, or because of cultural or religious barriers. Even with available donor tissues, the success rate for transplantation beyond the first few years is relatively low. The overall rate of graft rejection and failure with 24 months of transplantation is 10% in Sweden, a developed country, 9 and is about 50% in Australia after 5 years posttransplantation, 7 although it should be noted that the Australian cases comprised high-risk grafts. 7 .
The risk of transmitting infection through corneal transplantation must also be considered.
While extremely rare, this potential exists, and hence all donated corneas are screened at very high costs. Person-to-person transmission of the rabies virus 10 and at least one case of Creutzfeldt-Jakob disease 11 have been reported. Another concern is that yet unknown pathogens could be transmitted.
Within the past few years, significant developments have occurred in biomaterials and stem cell-based methods and combinations of both for use in replacing part or the full thickness of damaged or diseased corneas. Thus, other methodologies, such as regeneration of the ocular surface and other affected layers, have become important alternatives to conventional transplantation techniques. The best-known alternatives to human corneal allografts are "artificial corneas," a term applied to corneal prostheses or keratoprostheses (KPro's). Classical KPro's were developed using plastic-based materials and were designed to restore minimal light transmission and protective functions of the cornea. 12,13 These devices have now been used clinically but only as last resorts, as they are still associated with significant in vivo complications, such as extrusion/rejection, glaucoma, or retinal detachment. A number of reviews have addressed the use of traditional KPro's. [14] [15] [16] This review focuses on the regenerative approaches to restoration of corneal function, since these represent possible current and future alternatives to conventional donor transplantation.
III. Keratoprostheses and Biointeractive Implants with Regenerative Functions
In contrast to conventional KPro's, such as OOKP 17 Clearly, the interactions between the growth factor-modified polymer and the cells are complex and require further study but have significant potential to alter epithelization of KPro's materials.
Underlying surface modifications also appear to play a role in the extent of cell coverage, as well as the density of EGF on the surface and the presence of EGF in the cell culture medium. In contrast to stimulatory effects, epithelial cell attachment to certain parts of the keratoprosthesis must be inhibited to prevent epithelial downgrowth and retroprosthetic membrane formation.
Transforming growth factor beta (TGFβ) was investigated because of its previously demonstrated ability to inhibit epithelial growth and promote stromal keratocyte proliferation, hence its potential usefulness for modification of the stromal implant surface. However, the results observed on TGFβ-modified PDMS surfaces in vitro were opposite to those expected; keratocyte adhesion was inhibited and epithelial cell growth was enhanced by surface treatment, indicating the complex nature of growth factor-cell interactions. 31 Grafting of PEG to poly(methyl methacrylate) (PMMA) implants, which typically exhibit high protein deposition and cell adhesion associated with retroprosthetic membrane formation, was investigated. 32 The modification resulted in decreased keratocyte and inflammatory cell adhesion on the polymer surface in vitro and in rabbit experiments. 
B. Examples of KPro's with regenerative capabilities
Jacob and coworkers coupled cell adhesion peptides and various cytokines to poly (methacrylic) acid-co-2-hydroxyethyl methacrylate (PHEMA/MAA). 18 The addition of methacrylic acid monomers to PHEMA has the effect of increasing the water content to over 70% and, in turn, increasing the permeability of the hydrogel. They found that in vitro, corneal epithelial outgrowth was greatly enhanced on these substrates when laminin and fibronectin adhesion-promoting peptide were tethered to their surface via flexible PEG chains. Of notable importance is that the peptides and factors are exposed to biodegradation, and therefore, effort must be made to ensure that longterm attachment of the epithelial cells on the surface is maintained.
Myung and coworkers reported on a KPro consisting of a double network of PEG and PAA. 14 A recent version comprised of a photo-lithographically patterned device with a PEG/PAA central core and a poly (hydroxyethyl acrylate) (PHEA) micro-perforated skirt. Coupling of collagen type I to the hydrogel allowed for epithelial coverage in wound healing models both in vitro and in vivo in rabbits. 33 The latest iteration, comprising a single-piece KPro fabricated using a 2-step polymerization process is under investigation. First, a core-skirt construct is fabricated by photolithographic polymerization of PEG. This is followed by sequential polymerization and crosslinking of acrylic acid within the bulk of the PEG form. 
III

B. Hybrid Scaffolds and Nanocomposites for Promoting Regeneration
Although cross-linked collagen-only implants are adequately robust for suturing, their mechanical properties are insufficient to provide normal corneal tensile strength. However, strength can be improved by either co-polymerization with a synthetic network, or by introducing a second network, eg, as interpenetrating networks (IPNs). For example, a novel PNiPAAm-based polymer (poly (N-isopropylacrylamide-co-acrylic acid-co-acryloxysuccinimide) or its YIGSR-modified analog (co-polymers abbreviated to Terpolymer (TERP) and TERP5, respectively), was copolymerized with type I bovine atelocollagen to provide transparent hydrogels that were moldable to the curvature and dimensions of a normal cornea. 40 Collagen TERP5 hydrogels were implanted as lamellar grafts into host pig cornea with pig cornea allografts used as controls. This study reported for the first time the regrowth of corneal epithelial and stromal cells onto and into the implant, respectively, to reconstitute corneal tissue. This was accompanied by restoration of tear film mucin and regeneration of corneal nerves with concomitant recovery of touch sensitivity by 6
weeks post-operation. In contrast, allografted controls had no innervation or sensitivity within this period. Previous studies of restoration of touch sensitivity have indicated that only minimal function is detected, even 10 years after partial-thickness lenticule transplantation from a human donor cornea, 41 showing the feasibility of using biointeractive materials to induce rapid innervation. Whether or not such rapid innervation is desirable h yet to be determined. Using multifunctional dendrimers in place of TERP as the collagen crosslinker, Duan and Sheardown showed overall improved mechanical strength of their hydrogels. 42, 43 In addition, the presence of the additional functional groups allowed the gels to be modified with large and tunable amounts of biologically relevant functional groups. The maximum achievable YIGSR concentration of 3.1 x 10-2 mg/ml collagen is significantly greater than that obtained previously using the PNiPAAmbased crosslinking agent at 1.6x10-6 mg/mg of collagen. 44 More recently, Liu et al showed that biologically interactive corneal substitutes could also be fabricated from interpenetrating polymeric networks of collagen and a synthetic phosphorylcholine (lipid). 45 In this case, one network comprised of collagen (either porcine or recombinant human) crosslinked with 1-ethyl-3-(3-dimethyl aminopropyl) carbodiimide (EDC) and N-hydroxysuccinimide (NHS). The other network consisted of PEG diacrylate crosslinked 2-methacryloyloxyethyl phosphorylcholine (MPC). The resulting hydrogels showed an overall increase in mechanical strength beyond that of both original component and enhanced stability against enzymatic digestion by collagenase or ultraviolet light degradation. More importantly, these constructs retained the full biointeractive and cell-friendly properties of collagen in promoting corneal cell and nerve in-growth and regeneration in both normal animal models and alkali-burnt corneas, despite MPCs known anti-adhesive properties. These hydrogels had refractive indices, white light transmission and backscatter comparable or superior to those of human cornea. Glucose and albumin permeability were also comparable to those of human corneas.
Recently, the porcine collagen component of the hydrogel has been substituted with recombinant human collagen, resulting in a fully-synthetic implant that is free from the potential risks of disease transmission (eg, prions) present in animal source materials. Recent full-thickness collagen MPC implants into guinea pig corneas showed for the first time, by electrophysiology, that various subtypes of corneal sensory nerves regenerated and innervated the implants by 8 months postoperatively, ie, the nerves were functional. 46 This was in addition to the reconstitution of corneal tissue components within the implant by the in-growth of cells from endogenous progenitors. Similarly, recombinant human collagen-MPC implants in alkali-burnt rabbits also showed extensive regeneration. Collagen-MPC implants, compared to collagen-only implants, were able to prevent neovascularization.
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Bioactive collagen-based corneal substitutes can also incorporate micro-or nanoparticles that would release drugs to possibly treat existing conditions, thereby extending their functionality to a wider number of clinical indications. For example, the incorporation of a porous silica dioxide nanoparticle-encapsulated antiviral drug, Acyclovir, within a collagen-MPC hydrogel, was able to sustain drug release over 10 days to suppress viral activity in vitro. 48 In the future, such composite corneal constructs might be useful for prevention of viral reactivation and re-infection in high risk transplants such as of herpetic host corneas during surgery.
C. Decellularized Corneas as Scaffolds
The recent use of decellularized corneal stromas, eg, from bovine corneas 49 for seeding stromal cells, potentially allows for a "ready-made" scaffold with the necessary mechanical properties for reconstruction of a multi-layered human corneal equivalent. While human cadaveric corneas or animal corneas can be used, the porcine cornea appears particularly attractive because of its anatomic similarity to the human cornea. Recently, several groups have succeeded in preparing an acellular corneal stroma using nonionic detergent and/or several enzymes. They reported that the matrix structure of decellularized corneal stroma was preserved compared with that of native cornea. 49,51-54 To eliminate the toxic effect of chemicals, Hashimoto and coworkers used high-hydrostatic pressurization (HHP) to decellularize porcine corneas, which were then transplanted into rabbit corneas. 55 No immune reaction was observed and the turbid corneas became clear. Lee et al used freezing-thawingcentrifugation of porcine cornea to the remove cells from the cornea while preserving the stromal architecture. 56 Recently, Gonzalez-Andrades et al showed that strong salt solutions (1.5 M sodium chloride) to generate an acellular corneal stroma with adequate histologic and optical properties and human keratocytes were able to penetrate and spread within this scaffold with appropriate levels of cell differentiation.
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Despite the potential of these technologies, it should be noted that xenogeneic transplantation or use of poor quality cadaveric human corneas that cannot be used as living allografts will still pose the risk of disease transmission and will require screening, which will be costly.
IV. Cell-Based Regenerative Therapies
Regeneration of the human cornea using any of the above methods requires regeneration of one or more corneal components, such as the epithelium and stromal fibroblasts, and relies upon the Pelligrini and coworkers used cultured sheets of epithelium derived from a 1.00 mm 2 biopsy of healthy autologous tissue in two cases and showed improved vision in both patients. Two years later, both patients still had a stable corneal epithelium and an absence of vascularization, and had improved visual acuity with reduced symptoms of ocular pain and photophobia. 59 Since then, many other groups have reported beneficial results from autologous transplantation of corneal limbal epithelial stem cells to treat ocular surface disorders.
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Where both eyes have LSCD, allografted stem cells have been used. In these cases, LESCs have been cultured for transplantation from living related or cadaveric donor corneas. 63 The results have been promising in terms of improvement in ocular surface comfort and vision. 64 However, the mechanism of therapeutic efficacy remains unknown, as there is no evidence of long-term donor tissue survival. 65 The disadvantage of this technique is that the patient is required to undergo systemic immunosuppression, and even then, the donor cells do not survive over the long term. This has led to a search for autologous, noncorneal cell sources. Inatomi et al reported the successful autologous reconstruction of the corneal surface by transdifferentiation of oral mucosal epithelium. 66 The authors contend that the use of autologous cells may be safer than allogenic grafts for ocular resurfacing, in particular for younger patients with the most severe ocular surface disorders. However, it should be noted that all transplanted eyes had some peripheral corneal range of substrates have been tested (Table 1) , and several of these are described in detail below.
A. Corneal Epithelial Reconstruction
Use of fetal membranes as a surgical material for skin transplantation were first reported in
1910.
81, 82 They were first used in ophthalmic surgery for conjunctival tissue loss and repair of symblepheron. 83 The use of human amniotic membrane (HAM) as a carrier for limbal stem cells for transplantation was also pioneered by Tseng.
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HAM forms the inner wall of the membranous sac that surrounds and protects the embryo during gestation. 85 It is a translucent membrane whose structure consists of a single layer of epithelial cells attached to a thick basement membrane and an avascular stromal matrix. 86 Amniotic membrane can range in thickness from 0.02 mm to 0.5 mm, 82 and it remains devoid of blood vessels in vivo despite its close proximity to the highly vascular chorionic membrane. 86 Essentially, when stripped of its cell population, HAM essentially acts as a decellularized scaffold.
Unlike decellularized scaffolds, however, HAM has several additional unique characteristics that make it a popular surgical tool in corneal ocular surface reconstruction, eg, antiinflammatory, antiscarring and antiangiogenic properties. 86 Hao and coworkers showed that both human amniotic epithelial and mesenchymal cells express interleukin-1 receptor antagonist, all four members of the family of tissue inhibitors of metalloproteinase (TIMP), collagen XVIII, and interleukin-10, thus providing an explanation for the anti-inflammatory and antiangiogenic properties of amniotic membrane. 87 HAM also reduces scarring by suppressing TGF-β signalling and myofibroblast differentiation 88 and also produces growth factors that can stimulate epithelialization. 89 Koizumi et al demonstrated that EGF, transforming growth factor α (TGF α), keratinocyte growth factor (KGF), hepatocyte growth factor (HGF), basic fibroblast growth factor (bFGF) and TGF-β were expressed in amniotic membrane and may facilitate re-epithelialization. 77 Moreover, HAM can act as a basement membrane that enables the migration of cells through the presence of laminin isoforms. 82 HAM is now extensively used in ophthalmic surgery for corneal and conjunctival reconstruction. 86 Because of its healing properties, it can be used as a biological bandage to cover inflamed or exposed areas caused by surgery or injury. In these procedures, the amniotic membrane is sutured with the epithelial side facing the ocular surface. In corneal reconstruction, the amniotic membrane is used to treat LESC deficiencies, perforations, bullous keratopathy, and corneal ulcers. Despite the successful use of HAM, however, donated human tissues require careful screening, sterilization and preservation to prevent disease transmission. The use of synthetic, carrier-free constructs and biodegradable polymers can potentially avoid this risk. Alternatives tested are described below.
B. Biomaterials-Assisted Carrier-Free Transplantation of Corneal Cell Sheets
Okano's group in Japan developed an ingenious culture system based on synthetic polymer surfaces that allows for essentially carrier-free sheets of corneal epithelium to be cultured for transplantation. 78 recombinant human collagen type III as substrates and potential carriers for LESCs. 75 The thin hydrogels had a refractive index and transmission and backscatter properties that were similar to that of native cornea, and LESCs were able to stratify and express putative stem cell and differentiated cell type markers in a fashion similar to cells on AM.
C. Corneal Endothelial Reconstruction
Corneal endothelial replacement is fast becoming a popular surgical technique, as it replaces only the damaged or diseased endothelial layer. As such, biomaterials have now also been tested for their efficacy in supporting corneal endothelial proliferation and as carriers. Early carriers include stripped Descemet membrane. Other carriers tested include the range of materials used for LESCs.
Recombinant human collagen has also been tested as a carrier, but unlike the case with LESC, corneal endothelial cells did not grow well on the recombinant human type III collagen, although they grew on recombinant human type I membranes. 93 Corneal endothelial cells have recently become a popular target for cell seeding, for example, on lamellar matrices, with the goal of manufacturing grafts for lamellar keratoplasty. Primary endothelial cells are more difficult to cultivate than other cell types because of their minimal proliferative capacity. Several groups have been working on overcoming these problems.
Joyce discovered that proliferative capacity is mediated by a G1-phase inhibition of the endothelial cell cycle. 94 It could have been demonstrated that endothelial cells deriving from younger donors showed a higher proliferative capacity compared to cells of elderly donors.
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Importantly, the Joyce group had developed a culture medium for corneal endothelial cells in the meantime, widely adopted through other research groups, improving the cultivation process of these cells and allowing more in-depth studies on human primary cells.
As corneal endothelial cells are crucial to maintain the transparency of the entire cornea, loss of these cells below a critical threshold unavoidably results visual acuity loss up to blindness.
To prevent corneas from developing opaqueness through developing edema, sufficient corneal endothelial cell numbers can be maintained by preventing the cells from undergoing apoptosis (programmed cell death). Fuchsluger et al have demonstrated that gene therapy leads to increased cell survival after transduction of corneal endothelial cells with Bcl-xL or p35 . 96 Moreover, they
showed that during long-term corneal storage, donor corneas retain significantly higher density of corneal cells and that these cells retained physiological morphology. 97 While viral vectors were used in this method, 98 recent approaches turn to biodegradable nanoparticles as carriers of DNA .
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By targeting Rho/Rho kinase (ROCK) protein signaling using the specific inhibitor, Y-27632, which re-creates stem-like conditionsOkumura et al demonstrated enhanced corneal endothelial cell proliferation in vitro, and enhanced endothelial wound healing in vivo, in an animal model. 100 As they reported, a first human trial is under way to study the effect of this protein in corneal endothelial cell dysfunctions. Similarly, this protein could act as stimulator for cultivation of primary corneal endothelial cells with the long-term goal of tissue engineering grafts for lamellar transplantation. 101 Another approach undertaken by Mehta et al optimizes a culture medium for corneal endothelial cells.
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D. Multi-layer tissue engineered construct
Several groups of investigators have developed a self-assembly approach to reconstruct multi-layered corneal tissue equivalents, primarily as a research and testing tool, but applications in transplantation have also been discussed. 103 .
The self-assembly technique used by Germain and coworkers adds ascorbic acid to the culture medium to stimulate the secretion of collagen and other extracellular matrix molecules by dermal fibroblast cells. The resulting sheets of extracellular matrix macromolecules are then stacked together to form a stroma, and allowed to further integrate in culture. To complete the construct, an epithelium is seeded on top of the stromal stack. Such constructs were reported to show excellent corneal morphology, and the cells express appropriate tissue-specific markers. 104 More recently, Carrier et al followed up with a new self-assembled model comprising a stroma consisting of human corneal and dermal fibroblasts. 105 The authors contend that the combination of the corneal and dermal fibroblasts were more conducive to the formation of a welldifferentiated epithelium that showed higher re-epithelialization rates than just corneal fibroblasts alone. They showed that this model reproduced the microanatomy of the native human cornea. In addition, this model was able to reproduce a mechanistically accurate wound healing process and is therefore useful as a tool for studying wound healing, screening bioactive factors that could modulate wound healing, or as a pre-screen prior to animal testing. 105 Guo et al characterized the ECM macromolecules deposited by primary human corneal fibroblasts in such self-assembled corneal substitutes. The average culture took 4 weeks to produce a multi-layered construct of about 36 µm thickness. 106 These constructs were highly cellular and are morphologically similar to the stroma of mammalian corneas, with multiple, parallel layers of cells and small fibrillar ECM arrays.
The fibrils were between 27 and 51 nm, with a mean of 38.1 7.4 nm, compared to the 31 0.8 nm reported in adult human corneas (32).
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I. Immunological Considerations
Studies in mice have shown that each of the three corneal components--epithelium, stroma, and endothelium--are separately targeted in the rejection process. Donor epithelium is rapidly replaced (15 days in mice) by host epithelium, 107 while endothelial cell survival predicts whether or not the graft will "take." Plskova et al have calculated that graft failure occurs in mice when 53% of the endothelium is lost, 108 indicating that a significant loss of endothelial cells can be accommodated by surviving grafts.
Endothelial cell damage is mediated by immune cells (T cells and macrophages), which gain access to the posterior corneal surface by migrating from iris vessels through a fibrin network (clot) in the anterior chamber of the eye (Sosnova-Netukova, unpublished data).
Less is known concerning the relationship between stromal fibroblast survival and overall graft Loss of the donor epithelium and replacement with host epithelium is not immune-mediated, since donor epithelium was replaced equally rapidly in both syngeneic and allogeneic grafts. 107 As donor epithelial cells are lost, they are rapidly replaced by host epithelium, due to the strong proliferative potential of epithelial cells in a manner similar to that that occurs with any corneal epithelial injury.
It is clear that much of the immunological damage to donor corneal grafts is based on recognition of alloantigens expressed on donor cells. However, noncellular stromal components may also generate an immune response, particularly across species. Liu et al have recently shown that tissue engineered porcine collagen corneas grafted (full thickness) into mice did not induce a significant T cell response, but instead generated a low-grade antiporcine collagen Type-1 antibody response as early as 2 weeks post graft, which continued to rise over several weeks. 109 However, the main immunological response to the graft was a local innate immune response with formation of a retrocorneal membrane, which ultimately reduced clarity of the transplanted hydrogel. It was unclear whether this was linked to the systemic antibody response or simply due to an exaggerated innate immune response within the anterior chamber.
The variable success of limbal stem cell grafts has been attributed both to local inflammatory effects and to immune rejection. Experimentally in mice, while syngeneic grafts were fully accepted, allogeneic limbal stem cell allografts were rejected within 9 days and xenografts even more rapidly. 110 It would appear therefore that such grafts suffer the same risk from immune rejection as penetrating grafts, at least in mice.
Recently, the possibility of using stem cell therapy to restore corneal opacification has been considered. Human stem cells have been shown experimentally to promote clearing of the corneal opacity in lumican-deficient mice, and appeared not to induce an immune reaction. 111 A similar experiment was performed using human adipose-tissue derived stem cells inoculated into the rabbit cornea; no immune response was elicited and the cells survived up to 10 weeks.
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These remarkable cross-species experiments require verification, but theoretically it is possible that stem cells, which do not express MHC antigens and express very few surface markers, are "immunologically privileged" cells. When placed in an immunologically privileged tissue, such as the cornea, 113 stem cells will have "double privilege" and thus greater ability to avoid rejection. This novel concept requires further investigation.
VI. Reinnervation of biointeractive implants
Despite the high survival rates of allograft transplantation, for many years after surgery the cornea exhibits many changes in its cell structure and functions, particularly in corneal sensitivity.Penetrating and lamellar keratoplasty both need a 360º corneal incision that cuts stromal corneal nerves and results in a full nerve degeneration of the transplanted cornea.
Nerve regeneration after nerve lesion is present in adult corneas. However, morphology and functional characteristics of regenerated corneal nerves may change significantly. In a first step of neural regeneration, nerve processes distal to the site of lesion, that is, inside the graft, degenerate completely, while the central stumps of cut nerves start to regenerate, and in a second phase form neuroma-like structures near the graft-host border. Weeks afterward, some of the newly formed sprouts of the injured corneal sensory nerves begin to penetrate the denervated host cornea, contributing to the partial restoration of the corneal nerve architecture and sensitivity of the cornea after allograft transplantation. 114--117 However, even an apparent recovery of corneal innervations is produced, the nerve pattern is rather different from the original corneal nerve architecture. 118, 119 This may be due, at least in part, to the interruption of the uptake by the injured corneal nerve endings of nerve growth signal molecules produced by corneal cells. These growth factors, such as NGF, 120 suffer centripetal axonal transport to the trigeminal somata, where they regulate the expression of genes that encode membrane ion channel and receptor proteins. The absence of these molecular signals in lesioned trigeminal sensory neurons may induce both functional and morphological changes in regenerating neurons, associated to the up-and down-regulation of several genes, such as those encoding ion channels involved in neuronal excitability, which is the basis for ectopic discharges and abnormal responsiveness of lesioned sensory neurons. 116, 121, 122 In parallel with the morphological disturbances, lesioned corneal nerves present functional alterations evidenced by an altered threshold and an abnormal responsiveness to natural stimuli of the denervated areas. These abnormalities take months to recover and may never return to normal values.
Thus, denervation produced by nerve cut during keratoplasty causes a reduced (hypoesthesia) or complete (anesthesia) loss of sensitivity inside the transplanted button, followed by a slow recovery associated to the gradual regeneration of sensory nerves inside the graft, 123, 124 which may be induced by an enhanced local production of nerve growth factors after corneal surgical injury. This may explain, at least in part, the enhanced healing and sensory recovery exerted by exogenous NGF (provided by topical treatment or by transplantation NGF-rich tissues as amniotic membrane) in neuropathic corneal ulcers and limbal stem cell deficiency. 120, 125, 126 .
In addition to the reduced sensitivity observed after nerve lesion, spontaneous abnormal sensations (dysesthesias), including pain and dry eye sensations, also develope after corneal surgery. These abnormal sensations may be due to the activation of nonlesioned nerve endings in the host cornea by inflammatory mediators released after surgery, and also to the ectopic activity of regenerating sensory nerve stumps, similar to the aberrant sensations originated by neuromas at a lost limb ('phantom limb'). 127 Transplanted corneas may remain anesthetic for years, and sometimes the recovery of sensitivity is restricted to the periphery of the implant. This recovery of corneal sensitivity is directly associated with the degree of graft reinnervation and depends mainly on the type of primary disease underlying keratoplasty. In this sense, it is expected to have better sensitivity recovery after corneal transplant when the host corneal tissue and nerves are in a better condition, as in keratoconus. On the contrary, graft reinnervation and recovery of sensitivity recovery is expected to be worst when surgery is performed in a host cornea with a poor trophic status, as in several systemic and genetic diseases and injuries. Recovery is especially poor in such ocular infections as herpetic keratitis, where corneal innervation and sensitivity are altered in the host cornea before the surgical intervention. Considering the well-established idea that an adequate functional innervation is essential to preserve the trophic condition of the corneal tissue, attention should be paid to the recovery of corneal innervation after keratoplasty, which may be a key point to guarantee an adequate corneal trophism after transplantation and may determine corneal graft survival.
Several morphological studies have described corneal nerve regeneration after keratoplasty performed with allogeneic tissue 117, 128, 129 and bioengineered corneal substitutes 38, 40 in animal and human models. Recovery of touch corneal sensitivity at different times after keratoplasty has been also studied. 38, 128, 130, 131 The reported results suggest that nerve regeneration is present both in allograft transplants and artificial implants, being even faster in the artificial corneal substitutes. 
VII. Conclusion
Significant and exciting developments have taken place in regenerative medicine-based approaches to replace partial or the full-thickness areas of damaged or diseased corneas in the past several years. Biomaterials have been developed to assist in these reparative procedures, from keratoprostheses with regenerative capacities to implants that are designed as interactive scaffolds to promote endogenous regeneration. Biomaterials derived from natural, decellularized tissue to fabricated constructs have also been used as substrates for delivery of exogenous stem cell grafts.
Issues that have to be considered are immunological implications as well as the importance of reinnervation of grafts. However, taken together, the different approaches may soon be able to supplement the supply of post-mortem human corneas harvested for transplantation, or allow restoration of diseased or damaged corneas that cannot be treated by currently available techniques. 3.
